Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lamb

Showing results (11-20 of 244) with videos related to

Pageof 25
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2021
Tafamidis: A Review in Transthyretin Amyloid CardiomyopathyYvette N Lamb
Targeted Oncology|October 25, 2021
Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLCYvette N Lamb
Drugs|May 10, 2020
Ozanimod: First ApprovalYvette N Lamb
Paediatric Drugs|May 26, 2021
Viloxazine: Pediatric First ApprovalYvette N Lamb
Drugs|January 17, 2025
Correction: Fulzerasib: First ApprovalYvette N Lamb
Drugs|October 7, 2024
Vorasidenib: First ApprovalYvette N Lamb
Drugs|March 4, 2025
Tasurgratinib Succinate: First ApprovalYvette N Lamb
Drugs|May 21, 2022
Ganaxolone: First ApprovalYvette N Lamb
Drugs|June 11, 2022
Correction to: Nirmatrelvir Plus Ritonavir: First ApprovalYvette N Lamb
CNS Drugs|January 31, 2020
Pitolisant: A Review in Narcolepsy with or without CataplexyYvette N Lamb
Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:
Pageof 25
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2021
Tafamidis: A Review in Transthyretin Amyloid CardiomyopathyYvette N Lamb
Targeted Oncology|October 25, 2021
Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLCYvette N Lamb
Drugs|May 10, 2020
Ozanimod: First ApprovalYvette N Lamb
Paediatric Drugs|May 26, 2021
Viloxazine: Pediatric First ApprovalYvette N Lamb
Drugs|January 17, 2025
Correction: Fulzerasib: First ApprovalYvette N Lamb
Drugs|October 7, 2024
Vorasidenib: First ApprovalYvette N Lamb
Drugs|March 4, 2025
Tasurgratinib Succinate: First ApprovalYvette N Lamb
Drugs|May 21, 2022
Ganaxolone: First ApprovalYvette N Lamb
Drugs|June 11, 2022
Correction to: Nirmatrelvir Plus Ritonavir: First ApprovalYvette N Lamb
CNS Drugs|January 31, 2020
Pitolisant: A Review in Narcolepsy with or without CataplexyYvette N Lamb
Pageof 25